drugset / Trial / NCT00739297
The Safety and Effectiveness of MK0476 (Montelukast) in Patients With Chronic Asthma (0476-388)
RandomizedCrossoverDouble-blindTreatment
Summary
This study will test the safety and effectiveness of a range of doses of MK0476 (montelukast) compared to placebo on improved lung function in patients with chronic asthma.
Timeline
- Start
- 2008-07
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Montelukast | Other / unclassified | 25 ug | Inhaled |
| Subject | Montelukast | Other / unclassified | 50 ug | Inhaled |
| Subject | Montelukast | Other / unclassified | 100 ug | Inhaled |
| Subject | Montelukast | Other / unclassified | 250 ug | Inhaled |
| Subject | Montelukast | Other / unclassified | 500 ug | Inhaled |
| Subject | Montelukast | Other / unclassified | 1000 ug | Inhaled |